Asherman's syndrome secondary prevention: Difference between revisions

Jump to navigation Jump to search
WikiBot (talk | contribs)
Created page with "__NOTOC__ {{Asherman's syndrome}} Please help WikiDoc by adding content here. It's easy! Click here to learn about editing. ==Overview== ==Se..."
 
Saud Khan (talk | contribs)
No edit summary
 
(One intermediate revision by one other user not shown)
Line 1: Line 1:
__NOTOC__
__NOTOC__
{{Asherman's syndrome}}
{{Asherman's syndrome}}
 
{{CMG}}; '''Associate Editor-In-Chief:''' {{skhan}}
Please help WikiDoc by adding content here.  It's easy!  Click  [[Help:How_to_Edit_a_Page|here]]  to learn about editing.
 
==Overview==
==Overview==
==Secondary Prevention==
Reevaluation one to two weeks postoperatively after hysteroscopy to remove adhesions may allow earlier identification of recurrent scar tissue while immature and small in size, allowing resection before these adhesions worsen.
==References==
==References==
{{Reflist|2}}
{{Reflist|2}}


[[Category:Overview complete]]
[[Category:Disease]]
[[Category:Obstetrics]]
[[Category:Gynecology]]
[[Category:Surgery]]
[[Category:Fertility]]
[[Category:Abortion]]
[[Category:Needs content]]
[[Category:Needs content]]


{{WikiDoc Help Menu}}
{{WikiDoc Help Menu}}
{{WikiDoc Sources}}
{{WikiDoc Sources}}

Latest revision as of 17:33, 1 August 2022

Asherman's syndrome Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Asherman's syndrome from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Asherman's syndrome secondary prevention On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Asherman's syndrome secondary prevention

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Asherman's syndrome secondary prevention

CDC on Asherman's syndrome secondary prevention

Asherman's syndrome secondary prevention in the news

Blogs on Asherman's syndrome secondary prevention

Directions to Hospitals Treating Asherman's syndrome

Risk calculators and risk factors for Asherman's syndrome secondary prevention

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor-In-Chief: Saud Khan M.D.

Overview

Reevaluation one to two weeks postoperatively after hysteroscopy to remove adhesions may allow earlier identification of recurrent scar tissue while immature and small in size, allowing resection before these adhesions worsen.

References


Template:WikiDoc Sources